Literature DB >> 27237050

E3-Independent Constitutive Monoubiquitination Complements Histone Methyltransferase Activity of SETDB1.

Lidong Sun1, Jia Fang2.   

Abstract

Ubiquitination typically occurs through the sequential action of three enzymes catalyzing ubiquitin activation (E1), conjugation (E2), and ligation (E3) and regulates diverse eukaryotic cellular processes. Although monoubiquitination commonly confers nondegradative activities, mechanisms underlying its temporal and spatial regulation and functional plasticity still remain largely unknown. Here we demonstrate that SETDB1, a major histone H3K9 methyltransferase is monoubiquitinated at the evolutionarily conserved lysine-867 in its SET-Insertion domain. This ubiquitination is directly catalyzed by UBE2E family of E2 enzymes in an E3-independent manner while the conjugated-ubiquitin (Ub) is protected from active deubiquitination. The resulting constitutive lysine-867 monoubiquitination is essential for SETDB1's enzymatic activity and endogenous retrovirus silencing in murine embryonic stem cells. Furthermore, the canonical hydrophobic patch on the conjugated-Ub is critical for Ub protection and function. Together, our findings highlight an E3-independent mechanism for monoubiquitination and reveal mechanistic details of SETDB1's enzymatic activity and the functional significance of its SET-Insertion.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27237050      PMCID: PMC5346476          DOI: 10.1016/j.molcel.2016.04.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  34 in total

Review 1.  Signaling through monoubiquitination.

Authors:  S Sigismund; S Polo; P P Di Fiore
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 2.  Nonproteolytic functions of ubiquitin in cell signaling.

Authors:  Zhijian J Chen; Lijun J Sun
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

Review 3.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

4.  SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state.

Authors:  Steve Bilodeau; Michael H Kagey; Garrett M Frampton; Peter B Rahl; Richard A Young
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

Review 5.  Cellular strategies for making monoubiquitin signals.

Authors:  Harish N Ramanathan; Yihong Ye
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-08       Impact factor: 8.250

6.  ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.

Authors:  Hoon Ryu; Junghee Lee; Sean W Hagerty; Byoung Yul Soh; Sara E McAlpin; Kerry A Cormier; Karen M Smith; Robert J Ferrante
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

7.  Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.

Authors:  Toshiyuki Matsui; Danny Leung; Hiroki Miyashita; Irina A Maksakova; Hitoshi Miyachi; Hiroshi Kimura; Makoto Tachibana; Matthew C Lorincz; Yoichi Shinkai
Journal:  Nature       Date:  2010-02-17       Impact factor: 49.962

8.  Defining the human deubiquitinating enzyme interaction landscape.

Authors:  Mathew E Sowa; Eric J Bennett; Steven P Gygi; J Wade Harper
Journal:  Cell       Date:  2009-07-16       Impact factor: 41.582

9.  mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.

Authors:  Hengbin Wang; Woojin An; Ru Cao; Li Xia; Hediye Erdjument-Bromage; Bruno Chatton; Paul Tempst; Robert G Roeder; Yi Zhang
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

10.  Structural biology of human H3K9 methyltransferases.

Authors:  Hong Wu; Jinrong Min; Vladimir V Lunin; Tatiana Antoshenko; Ludmila Dombrovski; Hong Zeng; Abdellah Allali-Hassani; Valérie Campagna-Slater; Masoud Vedadi; Cheryl H Arrowsmith; Alexander N Plotnikov; Matthieu Schapira
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more
  18 in total

1.  Essential roles of Windei and nuclear monoubiquitination of Eggless/SETDB1 in transposon silencing.

Authors:  Ken Osumi; Kaoru Sato; Kensaku Murano; Haruhiko Siomi; Mikiko C Siomi
Journal:  EMBO Rep       Date:  2019-10-02       Impact factor: 8.807

2.  A nuclear licence to silence transposons.

Authors:  Poppy A Gould; Helen M Rowe
Journal:  EMBO Rep       Date:  2019-10-16       Impact factor: 8.807

3.  ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination.

Authors:  Takeshi Tsusaka; Chikako Shimura; Yoichi Shinkai
Journal:  EMBO Rep       Date:  2019-10-02       Impact factor: 8.807

4.  HP1 maintains protein stability of H3K9 methyltransferases and demethylases.

Authors:  Ryo Maeda; Makoto Tachibana
Journal:  EMBO Rep       Date:  2022-02-15       Impact factor: 8.807

Review 5.  Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression.

Authors:  Nirmalya Saha; Andrew G Muntean
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-26       Impact factor: 10.680

6.  Regulation of mammalian 3D genome organization and histone H3K9 dimethylation by H3K9 methyltransferases.

Authors:  Kei Fukuda; Chikako Shimura; Hisashi Miura; Akie Tanigawa; Takehiro Suzuki; Naoshi Dohmae; Ichiro Hiratani; Yoichi Shinkai
Journal:  Commun Biol       Date:  2021-05-13

Review 7.  Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3.

Authors:  Arno F Alpi; Viduth Chaugule; Helen Walden
Journal:  Biochem J       Date:  2016-10-15       Impact factor: 3.857

Review 8.  New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.

Authors:  Daniel Hormaechea-Agulla; Youngjo Kim; Min Sup Song; Su Jung Song
Journal:  Mol Cells       Date:  2018-03-20       Impact factor: 5.034

Review 9.  SETDB1 in cancer: overexpression and its therapeutic implications.

Authors:  Vanessa J Lazaro-Camp; Kiarash Salari; Xiangbing Meng; Shujie Yang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1.

Authors:  Connor Arkinson; Viduth K Chaugule; Rachel Toth; Helen Walden
Journal:  Life Sci Alliance       Date:  2018-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.